Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INCY | AMGN | REGN | VRTX | BMY |
| Company | Incyte Corp | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 63.94 | 335.84 | 1,162.05 | 490.00 | 49.50 |
| High | 66.48 | 337.46 | 1,162.05 | 490.15 | 50.25 |
| Low | 63.94 | 332.92 | 1,152.01 | 483.99 | 49.26 |
| Last | 66.41 | 335.26 | 1,153.08 | 489.43 | 49.99 |
| Change | +2.85 | +2.81 | -0.27 | +4.06 | +0.86 |
| % Change | +4.48% | +0.85% | -0.02% | +0.84% | +1.75% |
| Volume | 1,835,681 | 2,340,024 | 344,339 | 690,518 | 11,062,792 |
| 20-Day Average Volume | 1,800,314 | 1,694,551 | 414,632 | 964,456 | 8,645,196 |
| Previous Close | 63.56 | 332.45 | 1,153.35 | 485.37 | 49.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 64.18 | 328.79 | 1,172.45 | 481.27 | 49.01 |
| 20-Day Raw Stochastic | 83.10% | 88.08% | 40.67% | 72.65% | 80.34% |
| 20-Day Relative Strength | 58.66% | 57.57% | 53.76% | 55.81% | 59.06% |
| Weighted Alpha | +18.42 | +26.73 | +41.62 | +38.03 | -8.77 |
| Today's Opinion | 100% Buy | 88% Buy | 80% Buy | 72% Buy | 56% Buy |
| Previous Opinion | 64% Buy | 88% Buy | 80% Buy | 72% Buy | 56% Buy |
| Last Month's Opinion | 56% Buy | 72% Buy | 100% Buy | 56% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.67% since 09/09/24 | +2.87% since 09/09/24 | +0.73% since 09/09/24 | +3.89% since 09/09/24 | +3.07% since 09/09/24 |
| Low | 61.45 on 09/10/24 | 320.30 on 09/11/24 | 1,113.24 on 09/11/24 | 460.69 on 09/11/24 | 47.76 on 09/12/24 |
| High | 66.48 on 09/16/24 | 337.46 on 09/16/24 | 1,170.58 on 09/13/24 | 490.15 on 09/16/24 | 50.25 on 09/16/24 |
| 1-Month | |||||
| %Chg | +6.84% since 08/16/24 | +4.30% since 08/16/24 | -2.22% since 08/16/24 | +2.53% since 08/16/24 | +1.28% since 08/16/24 |
| Low | 61.15 on 09/05/24 | 319.00 on 09/06/24 | 1,113.24 on 09/11/24 | 460.69 on 09/11/24 | 46.88 on 08/22/24 |
| High | 67.48 on 08/29/24 | 337.46 on 09/16/24 | 1,211.20 on 08/27/24 | 500.25 on 08/30/24 | 50.75 on 09/04/24 |
| 3-Month | |||||
| %Chg | +6.92% since 06/14/24 | +12.27% since 06/14/24 | +11.25% since 06/14/24 | +1.81% since 06/14/24 | +21.33% since 06/14/24 |
| Low | 56.75 on 07/05/24 | 296.56 on 06/17/24 | 1,011.67 on 07/03/24 | 458.04 on 08/13/24 | 39.35 on 07/05/24 |
| High | 70.36 on 07/25/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 51.19 on 07/29/24 |
| 6-Month | |||||
| %Chg | +13.77% since 03/15/24 | +24.69% since 03/15/24 | +19.56% since 03/15/24 | +20.05% since 03/15/24 | -4.49% since 03/15/24 |
| Low | 50.35 on 04/30/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 39.35 on 07/05/24 |
| High | 70.36 on 07/25/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 54.47 on 03/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,271,826 | 178,337,824 | 127,083,008 | 125,251,192 | 99,591,424 |
| Shares Outstanding, K | 224,541 | 536,435 | 110,186 | 258,053 | 2,027,100 |
| Annual Sales | 3,695,650,000 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 45,006,000,000 |
| Annual Net Income | 597,600,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 8,025,000,000 |
| Last Quarter Sales | 1,043,760,000 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 12,201,000,000 |
| Last Quarter Net Income | -444,600,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,680,000,000 |
| 60-Month Beta | 0.73 | 0.61 | 0.12 | 0.40 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.82 on 07/30/24 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 10/29/24 | 10/29/24 | 11/07/24 | 11/04/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.600 on 07/05/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 792.00 | 17.75 | 30.31 | 0.00 | 35.21 |